Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doxycycline in Patients With Relapsed Cutaneous T-cell Lymphoma

NCT02341209 is registered in ClinicalTrials.gov with Rochester General Hospital as lead sponsor.

NCT NCT02341209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02341209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doxycycline in Patients With Relapsed Cutaneous T-cell Lymphoma
Lead sponsor
Rochester General Hospital
Phase
Phase 2
Overall status
Terminated
Start date
February 6, 2018
Completion date
February 6, 2021
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous t-cell lymphoma, mycosis fungoides, sezary syndrome